Significant Ownership of BAKER BROS. ADVISORS LP

Signature - Title
/s/ Scott L. Lessing - Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BAKER BROS. ADVISORS LP.

Notify me when BAKER BROS. ADVISORS LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BAKER BROS. ADVISORS LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KOD Kodiak Sciences Inc. Common Stock, $0.0001 par value per share 32.8% $417M 20.1M Baker Bros. Advisors LP 18 Dec 2025
PRLD Prelude Therapeutics Inc Common Stock, $0.0001 par value per share 23.5% $8.01M 10.3M Baker Bros. Advisors LP 12 Jun 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 18.9% $103M $46.5M 7.75M +81.9% Baker Bros. Advisors LP 01 Aug 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 17.1% $200M 23.5M Baker Bros. Advisors LP 27 Mar 2025
SERA Sera Prognostics, Inc. Class A Common Stock, $0.0001 par value per share 16.1% $18.4M 5.5M Baker Bros. Advisors LP 12 Feb 2025
REPL Replimune Group, Inc. Common Stock, $0.001 par value per share 14.3% $100M 11M Baker Bros. Advisors LP 07 Mar 2025
KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share 10.9% $551M $128M 8.68M +30.2% Baker Bros. Advisors LP 09 Dec 2025
KALA KALA BIO, Inc. Common Stock, $0.001 par value per share 9.99% $11.4M 745K 0% Baker Bros. Advisors LP 02 Oct 2025
IMTX Immatics N.V. Ordinary Shares, nominal value EUR 0.01 per share 9.95% $103M $16.4M 12.1M +18.9% Baker Bros. Advisors LP 30 Sep 2025
RYTM Rhythm Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.9% $361M 5.6M Baker Bros. Advisors LP 31 Mar 2025
NGNE Neurogene Inc. Common Stock, par value $0.000001 per share 7% $21.3M -$10.6M 992K -33.3% Julian C. Baker 30 Jun 2025
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.9% $95.2M 7.31M Baker Bros. Advisors LP 30 Jun 2025
CERS Cerus Corporation Common Stock, par value $0.001 per share 5.2% $15.9M -$4.57M 10M -22.3% Julian C. Baker 30 Sep 2025
RVMD Revolution Medicines, Inc. Common Stock, par value $0.0001 per share 5% $361M 9.36M Baker Bros. Advisors LP 30 Jun 2025
CADL Candel Therapeutics, Inc. Common Stock, par value $0.01 per share 4.99% $11.9M -$2.55M 2.46M -17.7% Baker Bros. Advisors LP 31 Mar 2025
BMEA Biomea Fusion, Inc. Common Stock, par value $0.0001 per share 4% $3.19M 1.45M Baker Bros. Advisors LP 31 Dec 2024
IGMS IGM Biosciences, Inc. Common Stock, $0.01 par value per share 0% $0 0 Baker Bros. Advisors LP 14 Aug 2025

Schedules 13D/G Reported by BAKER BROS. ADVISORS LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.